Appearance and Transmission of the COVID-19 Disease, an Approach to its Understanding: A Review
Journal of Disease and Global Health, Volume 16, Issue 2,
This review analyzed literature from online journals and peer-reviewed articles dating back to the year 2020 covering the emergence, transmission, mutation, and strategic responses of coronavirus diseases. Most of the studies related to those areas found that early responses would effectively limit and control the transmission of the novel coronavirus. Currently, the use of masks, the use of detergents, social distancing and limiting overcrowding are measures in place, even though daily cases and deaths continue to increase worldwide. Previous responses in 2019 included border closures and lockdowns, which were more stringent. The public should be aware of transmission routes (e.g., mouth, nose) and modes of transmission (e.g., sneezing, both permeable and impermeable inanimate objects) that put their health at risk, whether they are inside their homes or other environments such as the workplace or public spaces, as discussed in this document. The findings indicate that the implementation time of the strategies is significant, the increase in transmission will result in mutations that will affect many people, and in turn the development of new drugs in search of triggering a response in the cell, which results in the activation (stimulation) or deactivation (inhibition) of a symptom-improving effect and to counteract the inherent complications, as well as vaccines to increase the immune response in the body. The mutation is related to the spike protein which allows binding to the angiotensin-converting enzyme 2 receptor on human host cells. Additional research can be done on the evolution of new coronavirus strains to determine factors that can be disrupted to prevent resurgence or new occurrences.
- strategic responses
How to Cite
Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int J Antimicrob Agents. 2020;55(5): 105951. DOI: 10.1016/J.IJANTIMICAG.2020.105951
Balkhair AA. COVID-19 pandemic: A new chapter in the history of infectious diseases. Oman Med J. 2020;35(2) DOI: 10.5001/OMJ.2020.41
Gupta A et al. COVID-19: Emergence of infectious diseases, nanotechnology aspects, challenges, and future perspectives. Chemistry Select. 2020;5(25):7521–7533. DOI: 10.1002/SLCT.202001709.
Nguyen TT et al. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 Virus). Bio Rxiv. 2021;2020 .07.10.171769. DOI: 10.1101/2020.07.10.171769.
Vella F et al. Transmission mode associated with coronavirus disease 2019: A review. Eur Rev Med Pharmacol Sci. 2020;24(14):7889–7904. DOI: 10.26355/EURREV_202007_22296.
Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020;5: 248–255. DOI: 10.1016/J.IDM.2020.02.001.
He FJ, Tan M, Song J, Mac Gregor GA. Emergence of a novel human coronavirus threatening human health. Nature Medicine. 2020;26:3:317–319. DOI: 10.1038/s41591-020-0796-5.
Ouassou H et al. The pathogenesis of coronavirus disease 2019 (COVID-19): Evaluation and prevention. J Immunol Res; 2020. DOI: 10.1155/2020/1357983.
Qiu C et al. Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China. medRxiv. 2020.03.04.2002600. DOI: 10.1101/2020.03.04.20026005.
Jeng MJ. Coronavirus disease 2019 in children: Current status. Journal of the Chinese Medical Association. 2020;83(6): 527–533. DOI: 10.1097/JCMA.0000000000000323.
Noor FM, Islam MM. Prevalence and associated risk factors of mortality among COVID-19 patients: A meta-analysis. J Community Health. 2020;45(6):1270–1282. DOI:10.1007/S10900-020-00920-X/TABLES/3.
Docea AO et al. A new threat from an old enemy: Re-emergence of coronavirus (Review),” Int J Mol Med. 2020;45(6):1631–1643. DOI: 10.3892/IJMM.2020.4555/HTML.
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique. COVID-19 infection: Emergence, transmission and characteristics of human coronaviruses. J Adv Res. 2020;24 :91–98. DOI: 10.1016/J.JARE.2020.03.005.
Keni R, Alexander, A, Nayak PG, Mudgal J, Nandakumar K. COVID-19: Emergence, spread, possible treatments, and global burden. Front Public Health. 2020;8:536820 DOI: 10.3389/FPUBH.2020.00216/BIBTEX.
Rockett RJ et al. Revealing COVID-19 transmission by SARS-CoV-2 genome sequencing and agent based modeling. Bio Rxiv. 2020;2020.04.19.048751. DOI: 10.1101/2020.04.19.048751.
Wong SYS, Kwok KO, Chan FKL. What can countries learn from Hong Kong’s response to the COVID-19 pandemic?. CMAJ. 2020;192(19):E511–E515. DOI: 10.1503/CMAJ.200563/-/DC1.
Hwee Yong Tan T, Paul Han Sim Toh M. Coronavirus disease 2019 (COVID-19): The Singapore experience. A review of the first eight months. MRCP Department of Infection Prevention and Control. 2020;5. DOI:10.47102/annals-acadmedsg. 2020306.
Guo YR et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status. Mil Med Res. 2020;7(1):1–10. DOI: 10.1186/S40779-020-00240-0/TABLES/1.
Biswas A, Bhattacharjee U, Chakrabarti CV, Tewari DN, Banu H, Dutta S. Emergence of novel coronavirus and COVID-19: Whether to stay or die out?. 2020;46(2):182–193.
Available:https://doi.org/10.1080/1040841X.2020.1739001 DOI: 10.1080/1040841X.2020.1739001
Ritchie K, Chan D. The emergence of cognitive COVID. World Psychiatry. 2021;20(1):52–53. DOI: 10.1002/WPS.20837
Korber B et al. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812-827.e19 DOI: 10.1016/j.cell.2020.06.043.
Venkat Kumar G, Jeyanthi V, Ramakrishnan S. A short review on antibody therapy for COVID-19. New Microbes New Infect. 2020;35:100682. DOI: 10.1016/J.NMNI.2020.100682.
Meyers C et al. Lowering the transmission and spread of human coronavirus. J Med Virol. 2021;93(3):1605–1612
Hossain MP et al. The effects of border control and quarantine measures on global spread of COVID-19. SSRN Electronic Journal; 2020. DOI: 10.2139/SSRN.3551315.
Morawska L, Milton DK. It is time to address airborne transmission of coronavirus disease 2019 (COVID-19). Clinical infectious diseases. 2020;71(9): 2311–2313. DOI: 10.1093/CID/CIAA939.
Gan WH, Lim JW, Koh D. Preventing intra-hospital infection and transmission of coronavirus disease 2019 in Health-care Workers. Saf Health Work. 2020;11(2): 241–243. DOI: 10.1016/J.SHAW.2020.03.001.
Tan THY et al. Coronavirus disease 2019 (COVID-19): The singapore experience. a review of the first eight months. Ann Acad Med Singap. 2020;49(10):764–778. DOI:10.47102/annals-acadmedsg. 2020306.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;324(8): 782–793 DOI: 10.1001/JAMA.2020.12839
Abstract View: 0 times
PDF Download: 0 times